Search

Your search keyword '"FitzGerald, Liesel M."' showing total 323 results

Search Constraints

Start Over You searched for: Author "FitzGerald, Liesel M." Remove constraint Author: "FitzGerald, Liesel M."
323 results on '"FitzGerald, Liesel M."'

Search Results

8. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

9. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes

13. Novel Common Genetic Susceptibility Loci for Colorectal Cancer

14. Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants.

15. Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer.

16. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

17. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

18. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study

19. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.

21. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.

22. Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility.

23. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes

24. Discovery of common and rare genetic risk variants for colorectal cancer

25. Supplementary Methods, Figures S1 - S3 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

26. Supplementary Tables S1 - S10 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

27. Supplementary Acknowledgments from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

28. Data from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

29. Supplementary Grant Support from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

30. Appendix from Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk

31. Supplementary notes from Genome-Wide Association Study of Prostate Cancer–Specific Survival

32. Data from Genome-Wide Association Study of Prostate Cancer–Specific Survival

33. Supplementary Table 1 from Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk

34. Supplementary Table 1 from Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

35. Data from Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

36. Supplementary Table 2 from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

37. Supplementary Figure 1 from Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk

38. Supplementary Table 3 from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

39. Supplementary Figure 1 from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

40. Data from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

41. Supplementary Figure Legend from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

42. Supplementary Table 1 from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

48. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21

50. Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema

Catalog

Books, media, physical & digital resources